Laporan Laba Rugi 023910 - TTM - Daihan Pharmaceutical Co.,Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Daihan Pharmaceutical Co.,Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	170,116	166,080	162,372	165,495	166,619	171,463	173,726	177,126	181,122	184,268	189,043	192,259	194,528	195,912	198,834	198,052	201,974	204,195	205,067	207,677
Change (%)		-2.37	-2.23	1.92	0.68	2.91	1.32	1.96	2.26	1.74	2.59	1.70	1.18	0.71	1.49	-0.39	1.98	1.10	0.43	1.27
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	112,490	109,885	108,542	110,898	112,092	115,781	116,318	118,518	121,394	124,455	127,422	129,650	130,159	130,599	131,836	131,022	133,952	134,788	135,973	138,843
Change (%)		-2.32	-1.22	2.17	1.08	3.29	0.46	1.89	2.43	2.52	2.38	1.75	0.39	0.34	0.95	-0.62	2.24	0.62	0.88	2.11
% of Revenue	66.13	66.16	66.85	67.01	67.27	67.53	66.95	66.91	67.02	67.54	67.40	67.43	66.91	66.66	66.30	66.16	66.32	66.01	66.31	66.86

Gross Operating Profit	57,626	56,195	53,829	54,597	54,527	55,682	57,408	58,608	59,728	59,812	61,621	62,610	64,369	65,312	66,998	67,030	68,022	69,407	69,094	68,833
Change (%)		-2.48	-4.21	1.43	-0.13	2.12	3.10	2.09	1.91	0.14	3.02	1.60	2.81	1.47	2.58	0.05	1.48	2.04	-0.45	-0.38
% of Revenue	33.87	33.84	33.15	32.99	32.73	32.47	33.05	33.09	32.98	32.46	32.60	32.57	33.09	33.34	33.70	33.84	33.68	33.99	33.69	33.14

SG&A	25,185	24,573	24,471	24,362	24,212	24,781	24,985	25,050	25,482	25,411	25,994	26,207	26,654	26,956	27,338	27,773	28,098	28,445	28,685	29,035
Change (%)		-2.43	-0.42	-0.44	-0.61	2.35	0.83	0.26	1.73	-0.28	2.29	0.82	1.71	1.14	1.42	1.59	1.17	1.23	0.85	1.22
% of Revenue	14.80	14.80	15.07	14.72	14.53	14.45	14.38	14.14	14.07	13.79	13.75	13.63	13.70	13.76	13.75	14.02	13.91	13.93	13.99	13.98

R&D	384	689	909	1,035	977	791	586	476	556	568	607	617	1,425	1,641	1,805	2,097	1,683	1,802	2,145	2,180
Change (%)		79.34	31.86	13.90	-5.63	-19.06	-25.90	-18.78	16.91	2.09	6.88	1.59	131.06	15.19	9.95	16.18	-19.70	7.04	19.02	1.66
% of Revenue	0.23	0.41	0.56	0.63	0.59	0.46	0.34	0.27	0.31	0.31	0.32	0.32	0.73	0.84	0.91	1.06	0.83	0.88	1.05	1.05

OpEx	138,967	136,117	134,933	137,359	138,361	142,395	142,866	144,948	148,282	151,300	154,878	157,328	159,071	160,116	161,942	161,874	164,790	166,114	167,863	171,131
Change (%)		-2.05	-0.87	1.80	0.73	2.92	0.33	1.46	2.30	2.03	2.37	1.58	1.11	0.66	1.14	-0.04	1.80	0.80	1.05	1.95
% of Revenue	81.69	81.96	83.10	83.00	83.04	83.05	82.24	81.83	81.87	82.11	81.93	81.83	81.77	81.73	81.45	81.73	81.59	81.35	81.86	82.40

Operating Income	31,149	29,963	27,439	28,136	28,258	29,068	30,860	32,178	32,840	32,968	34,165	34,931	35,457	35,795	36,892	36,178	37,184	38,081	37,204	36,546
Change (%)		-3.81	-8.42	2.54	0.43	2.87	6.17	4.27	2.06	0.39	3.63	2.24	1.50	0.96	3.06	-1.94	2.78	2.41	-2.30	-1.77
% of Revenue	18.31	18.04	16.90	17.00	16.96	16.95	17.76	18.17	18.13	17.89	18.07	18.17	18.23	18.27	18.55	18.27	18.41	18.65	18.14	17.60

Interest Expense	-687	-617	-548	-490	-479	-469	-473	-491	-542	-593	-518	-383	-221	-52	-2	0	0	-2	-2	-3
Change (%)		-10.15	-11.21	-10.63	-2.16	-2.04	0.73	3.97	10.36	9.41	-12.65	-26.06	-42.44	-76.22	-96.93	-100.00	NaN	-∞	28.95	26.78
% of Revenue	-0.40	-0.37	-0.34	-0.30	-0.29	-0.27	-0.27	-0.28	-0.30	-0.32	-0.27	-0.20	-0.11	-0.03	-0.00	0.00	0.00	-0.00	-0.00	-0.00

Net Income	26,246	17,381	15,568	16,166	16,680	22,670	23,690	25,029	26,197	24,961	26,089	26,521	26,211	28,426	29,384	30,036	30,665	33,759	33,139	31,324
Change (%)		-33.78	-10.43	3.84	3.18	35.92	4.50	5.65	4.67	-4.72	4.52	1.65	-1.17	8.45	3.37	2.22	2.09	10.09	-1.84	-5.48
% of Revenue	15.43	10.47	9.59	9.77	10.01	13.22	13.64	14.13	14.46	13.55	13.80	13.79	13.47	14.51	14.78	15.17	15.18	16.53	16.16	15.08

Source: Capital IQ

Daihan Pharmaceutical Co.,Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)